𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? The knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success and delay in your IND and BLA applications. You'll hear from top regulatory experts like David Uguen (𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀), Shirley Bartido (𝗧𝗮𝗸𝗲𝗱𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀), Yao-Yao Zhu […]

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based […]

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace. The 6th Gene Therapy Analytical Development & CMC Summit […]

The advanced therapy immuno-inflammatory dermatology market is undergoing unprecedented expansion, as Johnson & Johnson make a $3.35B play for bispecific candidates, Alumis secured $259M series C and Galderma, Incyte, and Eli Lilly unveil late-breaking data. With a fast-evolving drug development landscape, remaining at the forefront of promising targets is now more crucial than ever. That's […]

Spurred by George Schett and Andreas Mackensen’s remarkable CAR-T results in SLE, the immunotherapy revolution for autoimmune diseases is the next “million-dollar question”. The Autoimmunity Pharma & Biotech Partnering Summit is the only event of its kind, laying enabled partnering on top of hyper-relevant scientific discussion specifically for immune reset and reconstitution therapies. VIEW THE […]

Discover the future of drug discovery at the inaugural Hit ID Summit! As chemical libraries and hit screening methods—including DNA-encoded libraries, high-throughput screening, fragment-based screening, and AI—continue to evolve, now is the time for medicinal chemists, computational chemists, and drug discovery leaders and innovators to unite at a dedicated forum. This unique event presents the […]

The Advanced Therapies Congress showcases the future of advanced therapies. Bringing Europe’s largest cell and gene therapy conference and exhibition to Philadelphia, the event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. This year, we will be expecting 1000+ […]

In the last 12 months, precision healthcare in the Asia-Pacific region has seen a surge in technology advancements, including NGS and laboratory developed tests, approvals such as a companion diagnostic test for lung cancer, and evolving regulations throughout the region. The World Companion Diagnostics & Liquid Biopsy Summit APAC has been put together to provide […]

Join us at the 2nd Donor Selection & Cell Source Summit - an unparalleled event dedicated to revolutionizing donor testing, screening, and cell source selection. This is your chance to be at the forefront of scalable allogeneic manufacturing and streamline both supply chain and process development. Why Attend? Dive Deep: Explore the latest global regulatory […]

The landmark FDA approval of the first MASH therapeutic, the orphan drug designation for systemic sclerosis trials, and the rapid advancement of IPF treatments through clinical phases have ignited a transformative era in fibrosis research. Now more than ever experts are doubling down on fibrosis. As the focus on innovative therapies intensifies, there is a […]

Mark your calendars for November because LEAP HR: Emerging Biopharma is back! Returning to Boston from November 19-20, this event is designed specifically for CHROs, CPOs, and Heads of HR at the heart of Emerging Biopharma organizations. Over the course of two days, we will unite the most senior leaders from Emerging Biopharma companies across […]

Join us at the inaugural Portfolio Strategy & Decision Making for Biopharma Summit - the must-attend event for pharma and biotech leaders seeking to sharpen their portfolio strategies in today’s dynamic market. Gain exclusive insights into leveraging advanced data analytics, forecasting tools, and innovative approaches to enhance decision-making. This summit will showcase real-world case studies […]

Liquid biopsies are revolutionizing clinical trials, emerging as a game-changing diagnostic tool for monitoring molecular residual disease and detecting disease resistance. This breakthrough enables precise patient stratification, ensuring they receive the most effective and safe treatments. The 3rd Liquid Biopsy Surveillance Summit returns as the leading East Coast forum solely dedicated to MRD detection in clinical trials […]

As structural biology tools and screening technologies advance, the GPCR super family continues to be a hot area of drug discovery, with the potential to treat a plethora of diseases. For the first time ever, the GPCRs-Targeted Drug Discovery Summit Europe is coming to London, with the aim of overcoming pharmacology challenges and advancing the […]